Heartseed
Heartseed Inc. (TSE: 219A) is a clinical-stage Japanese biotech pioneering allogeneic iPSC-based cardiac replacement therapy to restore heart function in advanced heart failure.
)
January 11-15, 2027 | San Francisco
January 11-15, 2027 | San Francisco
)
)
January 11-15, 2027 | San Francisco
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)